中国淀粉(03838)发布公告，其已根据上市规则第14A.44条委任中州国际融资有限公司(一间根据证券及 期货条例可进行第1类(证券交易)及第6类(就机构融资提供意见)受规管活动的持牌法团)为独立财务顾 问，以就热电厂建筑合同及其项下拟进行交易向独立董事委员会及独立股东提供意见。有关委任已获独 立董事委员会批准。 ...

Core Viewpoint - China Starch (03838) experienced a significant decline of over 8% in its stock price, attributed to disappointing mid-term results for 2025, which showed a decrease in both revenue and profit [1] Financial Performance - The company reported a revenue of 5.115 billion yuan, representing a year-on-year decrease of 9.4% [1] - Profit attributable to shareholders was 151 million yuan, down 29.47% compared to the previous year [1] Market Conditions - The decline in revenue was primarily due to a decrease in the average selling price of the company's products and a reduction in total sales volume [1] - The price of corn kernels, a key raw material, has significantly increased, adding pressure on the company's cost structure [1] - The company faced challenges from both declining product prices and rising raw material costs, which adversely affected gross profit and profit margins [1]

Core Viewpoint - China Starch (03838.HK) reported a decline in mid-term performance, with revenue decreasing by 9.40% year-on-year to RMB 5.115 billion, and net profit attributable to shareholders dropping by 29.47% to RMB 151 million [1] Financial Performance - Revenue for the period was RMB 5.115 billion, a decrease of 9.40% compared to the previous year [1] - Net profit attributable to shareholders was RMB 151 million, down 29.47% year-on-year [1] - Basic earnings per share were RMB 0.0254 [1] Market Conditions - The decline in revenue was primarily due to a decrease in the average selling price of the company's products and a reduction in total sales volume [1] - The price of corn kernels, a key raw material, significantly increased during the period [1] Profitability Challenges - The company faced pressure from both declining product prices and rising raw material costs, leading to a reduction in gross profit [1] - These adverse changes have significantly impacted the company's profit margins [1]

【SynBioCon】 获 悉，4月14日， 中粮生物科技股份有限公司发布 了 关于 新建太仓年产 55 万 吨淀粉糖项目 的公告 。 具体情况如下： 一、项目投资概述 项目名称：中粮科技太仓 55 万吨 / 年淀粉糖新建项目。 总投资额：98,105 万元。其中建设投资 83,747 万元，建设期利息 1,451 万元，流动资金 12,907 万 元。具体以项目实际情况为准。 资金来源：资本金 43,494 万元，银行贷款 54,611 万元。 建设周期：自董事会批复项目之日至投料试车共 20 个月。 投资主体：中粮生物科技(太仓)有限公司（拟成立的全资子公司）。 建设地点：江苏省太仓市太仓港经济技术开发区。 本次项目投资事项不构成关联交易，亦不构成《上市公司重大资产重组管理办法》规定的重大资产重 组。 二、项目建设的必要性和可行性 1. 项目建设的必要性 。公司根据产业升级和消费需求，大力发展食品主业， 聚焦淀粉糖业务，建立行业领先地位，符合公司战略发展方向。项目建成后，将有助于完善淀粉糖业务 布局，提升公司的整体竞争力和盈利水平，有利于公司淀粉糖业务可持续发展。 2.项目建设的可行性 。华东地区作为中国 ...